Aclidinium Bromide Post-Authorisation Safety Study to Evaluate the Risk of Cardiovascular Endpoints

Clinical trial NCT03290287 · COMPLETED

Trial details

NCT number: NCT03290287
Sponsor: AstraZeneca
Status: COMPLETED
Study type: OBSERVATIONAL

Pulmonary Disease, Chronic Obstructive

Start date: 2017-03-01
Primary completion: 2022-06-30
Enrollment: 26839

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.